Skip to main content
. Author manuscript; available in PMC: 2024 Jun 28.
Published in final edited form as: Shock. 2023 Jan 10;59(4):540–546. doi: 10.1097/SHK.0000000000002079

Table 4.

Summary of tissue and EGL biomarker quantification at the time of operation (OR) and 24–48 hours after operation

Assay OR 24–48 h
CD138 (peritoneum), cells per HPF 1 (1)
CD138 (pathology), cells per HPF 3 (1–6)
Hyaluronic acid (plasma), ng/mL 537.9 (286.7–1032.6) 423.6 (159.1–733.6)
Syndecan-1 (plasma), ng/mL 35.2 (13.1–46.8) 51.2 (19.6–85.6)

CD138 positivity is presented as counts within a high-powered field (400 ×, 0.237 mm2) with IQR.

HPF, high-power field; OR, operating room; SOFA, Sequential Organ Failure Assessment.